Alexander Weng

2.2k total citations
69 papers, 1.8k citations indexed

About

Alexander Weng is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, Alexander Weng has authored 69 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Immunology, 46 papers in Molecular Biology and 14 papers in Biotechnology. Recurrent topics in Alexander Weng's work include Toxin Mechanisms and Immunotoxins (46 papers), Natural product bioactivities and synthesis (25 papers) and Transgenic Plants and Applications (14 papers). Alexander Weng is often cited by papers focused on Toxin Mechanisms and Immunotoxins (46 papers), Natural product bioactivities and synthesis (25 papers) and Transgenic Plants and Applications (14 papers). Alexander Weng collaborates with scholars based in Germany, United Kingdom and United States. Alexander Weng's co-authors include Matthias F. Melzig, Hendrik Fuchs, Mayank Thakur, Roger Gilabert‐Oriol, Christopher Bachran, Diana Bachran, Fuchs, Werner G. Daniel, Atilla Yılmaz and Christine Reiss and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Alexander Weng

64 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Weng Germany 24 1.0k 892 366 313 133 69 1.8k
Doo‐Byoung Oh South Korea 27 1.6k 1.5× 362 0.4× 403 1.1× 225 0.7× 59 0.4× 92 2.1k
Haya Lorberboum‐Galski Israel 23 922 0.9× 607 0.7× 297 0.8× 118 0.4× 46 0.3× 63 1.7k
Jin‐Chul Kim South Korea 27 972 0.9× 430 0.5× 70 0.2× 231 0.7× 116 0.9× 90 2.0k
Yu Sam Kim South Korea 21 1.3k 1.3× 325 0.4× 169 0.5× 260 0.8× 78 0.6× 58 2.0k
Rosita Russo Italy 21 824 0.8× 307 0.3× 164 0.4× 176 0.6× 42 0.3× 83 1.4k
Andrzej Rapak Poland 19 834 0.8× 504 0.6× 232 0.6× 162 0.5× 80 0.6× 62 1.7k
Hervé Benoist France 21 846 0.8× 579 0.6× 136 0.4× 61 0.2× 113 0.8× 83 1.7k
Xiaoge Gao China 23 958 0.9× 430 0.5× 65 0.2× 363 1.2× 203 1.5× 53 1.7k
Chung Park United States 24 885 0.8× 527 0.6× 183 0.5× 42 0.1× 59 0.4× 66 1.6k
Xuezhi Bi Singapore 29 1.2k 1.1× 215 0.2× 141 0.4× 155 0.5× 104 0.8× 76 2.1k

Countries citing papers authored by Alexander Weng

Since Specialization
Citations

This map shows the geographic impact of Alexander Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Weng more than expected).

Fields of papers citing papers by Alexander Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Weng. The network helps show where Alexander Weng may publish in the future.

Co-authorship network of co-authors of Alexander Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Weng. A scholar is included among the top collaborators of Alexander Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Weng. Alexander Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weng, Alexander, et al.. (2025). EKO-YAM - investigating Dioscorea for a sustainable future. Phytochemistry Letters. 69. 103685–103685.
2.
Sendker, Jandirk, Eike R. Hrincius, Stephan Ludwig, et al.. (2025). Antiviral activity against HSV-1 of triterpene saponins from Anagallis arvensis is related tothe fusion-inhibitory activity of desglucoanagalloside B. Fitoterapia. 184. 106620–106620.
3.
Weise, Christoph, et al.. (2024). Mutational Analysis of RIP Type I Dianthin-30 Suggests a Role for Arg24 in Endocytosis. Toxins. 16(5). 219–219. 1 indexed citations
4.
5.
Woith, Eric, et al.. (2021). Suicide nanoplasmids coding for ribosome-inactivating proteins. European Journal of Pharmaceutical Sciences. 170. 106107–106107. 5 indexed citations
6.
Jerz, Gerold, et al.. (2018). Plant derived triterpenes from Gypsophila elegans M.Bieb. enable non-toxic delivery of gene loaded nanoplexes. Journal of Biotechnology. 284. 131–139. 9 indexed citations
7.
Manunta, Maria, Aristides D. Tagalakis, Martin Attwood, et al.. (2017). Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: a therapeutic strategy for cystic fibrosis. Scientific Reports. 7(1). 700–700. 51 indexed citations
8.
Gilabert‐Oriol, Roger, Sebastian G. B. Furness, Brett W. Stringer, et al.. (2017). Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma. Cancer Immunology Immunotherapy. 66(9). 1217–1228. 16 indexed citations
9.
Jerz, Gerold, et al.. (2017). Sapofectosid – Ensuring non-toxic and effective DNA and RNA delivery. International Journal of Pharmaceutics. 534(1-2). 195–205. 14 indexed citations
10.
Weng, Alexander, Maria Manunta, Mayank Thakur, et al.. (2015). Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides. Journal of Controlled Release. 206. 75–90. 27 indexed citations
11.
Gilabert‐Oriol, Roger, et al.. (2014). Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy. Current Pharmaceutical Design. 20(42). 6584–6643. 62 indexed citations
12.
Bachran, Christopher, et al.. (2014). Triterpenoid saponin augmention of saporin-based immunotoxin cytotoxicity for human leukaemia and lymphoma cells is partially immunospecific and target molecule dependent. Immunopharmacology and Immunotoxicology. 37(1). 42–55. 23 indexed citations
13.
Gilabert‐Oriol, Roger, Mayank Thakur, Thomas Hug, et al.. (2013). Abstract A83: Combinatorial approach to drastically enhance the monoclonal antibody efficacy in targeted tumor therapy.. Molecular Cancer Therapeutics. 12(11_Supplement). A83–A83.
14.
Gilabert‐Oriol, Roger, et al.. (2013). Real-time analysis of membrane permeabilizing effects of oleanane saponins. Bioorganic & Medicinal Chemistry. 21(8). 2387–2395. 48 indexed citations
15.
Thakur, Mayank, Alexander Weng, Roger Gilabert‐Oriol, et al.. (2013). Macromolecular interactions of triterpenoids and targeted toxins: Role of saponins charge. International Journal of Biological Macromolecules. 61. 285–294. 18 indexed citations
16.
Weng, Alexander, Mayank Thakur, Figen Beceren‐Braun, et al.. (2012). The toxin component of targeted anti‐tumor toxins determines their efficacy increase by saponins. Molecular Oncology. 6(3). 323–332. 39 indexed citations
17.
Weng, Alexander, Mayank Thakur, Figen Beceren‐Braun, et al.. (2012). Saponins modulate the intracellular trafficking of protein toxins. Journal of Controlled Release. 164(1). 74–86. 64 indexed citations
18.
Fuchs, Hendrik, Diana Bachran, Alexander Weng, et al.. (2009). Saponins as Tool for Improved Targeted Tumor Therapies. Current Drug Targets. 10(2). 140–151. 64 indexed citations
19.
Weng, Alexander, Christopher Bachran, Hendrik Fuchs, & Matthias F. Melzig. (2008). Soapwort saponins trigger clathrin-mediated endocytosis of saporin, a type I ribosome-inactivating protein. Chemico-Biological Interactions. 176(2-3). 204–211. 22 indexed citations
20.
Yılmaz, Atilla, Christine Reiss, Alexander Weng, et al.. (2003). HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis. 172(1). 85–93. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doo‐Byoung Oh Breakdown of academic impact, for papers by Haya Lorberboum‐Galski Breakdown of academic impact, for papers by Jin‐Chul Kim Breakdown of academic impact, for papers by Yu Sam Kim Breakdown of academic impact, for papers by Rosita Russo Breakdown of academic impact, for papers by Andrzej Rapak Breakdown of academic impact, for papers by Hervé Benoist Breakdown of academic impact, for papers by Xiaoge Gao Breakdown of academic impact, for papers by Chung Park Breakdown of academic impact, for papers by Xuezhi Bi
Rankless by CCL
2026